See up to 3 months of SAVA. The 7-day demo opens the 1M and 3M ranges and puts SAVA on your watchlist.
Start 7-day demoLatest SAVA insider trades
About CASSAVA SCIENCES INC (SAVA)
CASSAVA SCIENCES INC files with the SEC under CIK 0001069530 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
SAVA Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 3 | 399,904 | $356K |
SAVA insider transactions (Form 4)
3124 Form 4 filings on record, the earliest from Oct 1, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Richard Barry - Officer | Open-market purchase | Common Stock | 206,813 | $0.90 footnote F1 | $186K | |
| Richard Barry - Officer | Open-market purchase | Common Stock | 100,000 | $0.92 footnote F2 | $92K | |
| ||||||
| Richard Barry - Officer | Open-market purchase | Common Stock | 93,091 | $0.84 footnote F1 | $78K | |
| ||||||
| Robert Eugene Anderson Jr. - Director | Open-market purchase | Common Stock | 8,600 | $2.90 | $25K | |
| Richard Barry - Officer | Open-market purchase | Common Stock | 150,000 | $2.76 footnote F1 | $414K | |
| ||||||
| Richard Barry - Officer | Open-market purchase | Common Stock | 73,385 | $2.75 footnote F1 | $202K | |
| ||||||
| Dawn Carter Bir - Director | Grant or award | Stock Option (Right to Buy) | 53,000 | $0.00 | - | |
| Robert Christopher Cook - Officer | Open-market purchase | Common Stock | 13,725 | $2.91 | $40K | |
| Richard Barry - Officer | Open-market purchase | Common Stock | 7,172 | $2.28 | $16K | |
| Richard Barry - Officer | Open-market purchase | Common Stock | 5,400 | $2.13 | $12K | |
| Richard Barry - Officer | Open-market purchase | Common Stock | 185,233 | $2.24 | $415K | |
| Richard Barry - Officer | Open-market purchase | Common Stock | 400 | $2.25 | $900 | |
| Richard Barry - Officer | Open-market purchase | Common Stock | 46,908 | $2.29 | $107K | |
| Robert Eugene Anderson Jr. - Director | Grant or award | Stock Option (Right to Buy) | 26,500 | $0.00 | - | |
| Robert Z. Gussin - Director | Grant or award | Stock Option (Right to Buy) | 26,500 | $0.00 | - | |
 Pierre Gravier - Director | Grant or award | Stock Option (Right to Buy) | 26,500 | $0.00 | - | |
| Claude Nicaise - Director | Grant or award | Stock Option (Right to Buy) | 26,500 | $0.00 | - | |
| Donnell Michael J. O. - Director | Grant or award | Stock Option (Right to Buy) | 26,500 | $0.00 | - | |
| Patrick J. Md Phd Scannon - Director | Grant or award | Stock Option (Right to Buy) | 26,500 | $0.00 | - | |
| Eric Schoen - Officer | Grant or award | Stock Option (Right to Buy) | 100,000 | $0.00 | - | |
| Richard Barry - Officer | Grant or award | Stock Option (Right to Buy) | 350,000 | $0.00 | - | |
| Freda Nassif - Officer | Grant or award | Stock Option (Right to Buy) | 100,000 | $0.00 | - | |
| Robert Christopher Cook - Officer | Grant or award | Stock Option (Right to Buy) | 100,000 | $0.00 | - | |
| James William Kupiec - Officer | Open-market sale | Common Stock | 4,000 | $3.87 | $15K | |
| Eric Schoen - Officer | Option exercise | Common Stock | 50,000 | $1.18 | $59K | |
| Eric Schoen - Officer | Open-market sale | Common Stock | 2,000 | $3.82 | $8K | |
| Eric Schoen - Officer | Open-market sale | Common Stock | 59,800 | $3.86 | $231K | |
| Eric Schoen - Officer | Option exercise | Stock Option (Right to Buy) | 50,000 | $0.00 | - | |
| Jaren Landen - Officer | Grant or award | Stock Option (Right to Buy) | 85,000 | $0.00 | - | |
| Freda Nassif - Officer | Grant or award | Stock Option (Right to Buy) | 100,000 | $0.00 | - | |
| Richard Barry - Officer | Grant or award | Stock Option (Right to Buy) | 600,000 | $0.00 | - | |
Item 7.01, 8.01, 9.01
Item 3.01
Item 2.02, 9.01
Item 5.02, 5.07, 9.01
SAVA insider trading FAQ
What is the latest insider trade for SAVA?
CASSAVA SCIENCES INC (SAVA) had 2 insider filings in the last 90 days, with the most recent on 2026-10-01. The full record for SAVA runs to 24 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SAVA stock?
3 insider purchases of SAVA were filed in the last 90 days, totaling $356K.
How many insiders are selling SAVA stock?
No insider sales of SAVA were filed in the last 90 days. 3 sales are on record for this company.
Where can I see SAVA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SAVA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Richard Barry view on EDGAR
- - Richard Barry view on EDGAR
- - Robert Eugene Anderson Jr. view on EDGAR
- - Richard Barry view on EDGAR
- - Richard Barry view on EDGAR
- - Dawn Carter Bir view on EDGAR
- - Robert Christopher Cook view on EDGAR
- - Richard Barry view on EDGAR
- - Richard Barry view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where SAVA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SAVA with a 7-day demo
- SAVA on your watchlist
- Every SAVA Form 4 filing on record
- Up to 3 months of SAVA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
